• #38 - Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals

  • May 8 2024
  • Duración: 22 m
  • Podcast

#38 - Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals Por arte de portada

#38 - Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Join us on the latest episode! Our Guest: Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals.

    What you'll get out of this episode:

    • Dr. Michael Kyle's Background: Insights into his journey from medical practice to becoming SVP & Chief Medical Officer of Currax Pharmaceuticals.
    • Understanding Obesity: A discussion on different types of obesity and the importance of tailored treatments.
    • Global Perspectives: Comparing how the U.S. and European countries handle obesity and the lessons to be learned.
    • Evolving Treatments: The parallel evolution of hypertension and obesity treatments.
    • Behavioral Approaches: The importance of sustainable lifestyle changes and behavior modification in addressing obesity.


    To learn more about our guests and their companies:
    LinkedIn https://www.linkedin.com/in/michael-l-kyle/
    Company LinkedIn https://www.linkedin.com/company/currax-pharmaceuticals-llc/
    Website https://www.curraxpharma.com/

    Our sponsor for this episode are:
    Sage Growth Partners https://sage-growth.com/

    BioBreakthroughs is part of the Slice of Healthcare podcast network:
    LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
    Más Menos
activate_primeday_promo_in_buybox_DT
Empresas y Profesiones Política y Gobierno Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre #38 - Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles